http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
송주흥(Ju Hung Song),최인태(In Tae Choi),채수인(Soo In Chae),김영준(Young June Kim),나용호(Yong Ho Na) 대한소화기학회 1986 대한소화기학회지 Vol.18 No.1
A prospective esophageal manometry using the high-fidelity recording equipment was performed in 35 healthy Korean. The manometric data of this study showed: 1) 3.4(+-0.67)cm for LES length; 19.8(+-7.05)mmHg for LES pressure; 7.43(+-2.21) sec. For the relaxation time of LES; 21.9(+-2.7)cm for the length of esophageal body; 28.3(+-13)~ 55.7(+-11)mmHg for the amplitude of esophageal contractions; 3.2(+-0.6)~3.8(+-1.0)sec. For the duration of the contraction waves; 3.1(+-1.2)~6.6(+-2.3)cm/sec. For the velocity of the contraction waves; 2.6(+-0.9)cm for UES length; 0.95(+-0.3)sec. For the relaxation time of UES, 2) Radial pressure asymmetry of the LES was observed. The highest pressure occurred in the posterior direction and the lowest pressure in the right direction. 3) Abnormal esophageal responses to swallowing including aperistalsis, breaking waves, simultaneous contraction, spontaneous contraction, double peaked contraction and repetitive contraction were observed rarely in healthy subjects.
나용호(Yong Ho Nah),송주흥(Ju Hung Song),최인태(In Tae Choi),채수인(Soo In Chae),김영준(Young June Kim) 대한소화기학회 1986 대한소화기학회지 Vol.18 No.1
We performed the percutaneous endoscopic gastrostomy in 7 patients who were unable to swallow. Feeding via with the PEG was carried out in a bolus fashion requiring no additional equipment. In our experience no aspiration occurred and only one case of skin care problem arose. The PEG appeared to be safe and effective means of nonvolitional feeding in the home, hospital or in an extended care facility.
위장관 ( 胃腸管 ) : 위식도 역류질환에서 Cisapride가 보행성 24시간 식도내 pH 기록에 미치는 영향
나용호(Yong Ho Nah),송주흥(Ju Hung Song) 대한소화기학회 1990 대한소화기학회지 Vol.22 No.3
N/A To evaluate the effect of cisapride on gastroesophageal reflux, 42 patients with gastroesophageal reflux disease were studied. Patients were subdivided into two groups; cisapride group (n=28) and placebo group (n= 14). Tewenty-four hour ambulatory esophageal pH monitoring was done before and after treatment with placebo or 10 mg cisapride QID for 8 weeks. The results were as follows: 1) No significant differences in age, weight, duration of illness, lower esophageal sphincter pressure and amplitude of distal esophageal contractions were found between two groups. 2) In baseline study, no significant differences in 24-hour pH profile were demonstrated between two groups. 3) Cisapride was shown to increase the basal lower esophageal sphincter pressure as well as the amplitude of esophageal peristalsis, compared with placebo (p<0.01). 4) After treatment, 24-hour pH profile (number of reflux episodes lasting longer than 5 min, duration of the longest reflux episode, total percent of time pH less than 4) showed that there was significantly less reflux with cisapride than with placebo and its effect was most marked during supine position (p<0.01). 5) At the end of the treatment, follow-up endoscopy showed that previqus mucosal erosions or ulcers were absent in 8 of 11 patients in the cisapride group and in 1 of 5 patients in the placebo group. In conclusion, cisapride decreases pathologic reflux in gastroesophageal reflux disease. Of major interest is cisapride effect most marked at night.
저용량 Erythropoietin 을 투여받고 있는 혈액 투석환자에서 빈혈과 영양지표에 대한 안드로겐 병용투여의 효과
이명수(Myeung Su Lee),안선호(Seon Ho Ahn),송주흥(Ju Hung Song) 대한내과학회 2001 대한내과학회지 Vol.61 No.6
Background: Recombinant human erythropoietin (rHuEPO) has become attractive option of anemia therapy in chronic hemodialysis patients, but the use of rHuEPO is primarily limited by its high cost. So, the current cost-containment policy renders valuable any strategies that enhances the erythropoietic response to rHuEPO, thus resulting in lower rHuEPO dosing. Before the widespread availability of rHuEPO, androgen was the mainstay of nontransfusional therapy for the anemia of end-stage renal failure. However, previous studies that used androgen to enhance the response to rHuEPO showed variable results. Methods: We carried out a prospective study to examine the effect of adjuvant androgen on anemia and nutritional parameters in chronic hemodialysis patients using low-dose rHuEPO. Studies were performed in seventeen hemodialysis patients previously treated with low-dose rHuEPO (1,000 U rHuEPO subcutaneously three times a week), mean hemoglobin < 9.0 g/dL for 6 months (group A: before adjuvant androgen therapy). Same patients received the same dose of rHuEPO plus nandrolone decanoate 100 mg intramuscularly weekly for 6 months (group B: after adjuvant androgen therapy). Results: Transferrin saturation, serum ferritin, intact serum parathyroid hormone, plasma aluminium, ALT, ESR, albumin, PCRn and Kt/V were not significantly changed before and after adjuvant androgen therapy. The increase in hemoglobin and hematocrit in the group B was statistically greater than in the group A, respectively (8.99±1.39 g/dL vs 7.75±0.90 g/dL; p=0.001, 26.66±3.91% vs 23.68±2.85%; p= 0.003, respectively). With the exception of mild discomfort at the injected site, there were no significant side effects from nandrolone decanoate. Conclusion: Adjuvant androgen in patients treated with low-dose rHuEPO is effective treatment for the anemia of poor responsive patients to low-dose rHuEPO and lower the economical cost compared with the higher dose rHuEPO treatment alone.(Korean J Med 61:641-649, 2001)
김기훈 ( Ki Hoon Kim ),이명수 ( Myeung Su Lee ),심혁 ( Hyuk Sim ),안선호 ( Seon Ho Ahn ),송주흥 ( Ju Hung Song ),박도심 ( Do Sim Park ),이영진 ( Young Jin Lee ) 대한내과학회 2003 대한내과학회지 Vol.64 No.5
In 1955 Gasser and his associates describe the hemolytic uremic syndrome, which is characteristics of clinical manifestation such as microangiopathic hemolysis, thrombocytopenia, acute renal failure. The etiology of the syndrome remains unclear. Typical f
무뇨와 측복통으로 내원한 신증후성 출혈열 환자에서 신 피막 자연 파열에 의한 후복막강 혈종
이재훈(Jae Hoon Li),박정현(Jeong Hyun Park),이명수(Myeung Su Lee),안선호(Seon Ho Ahn),송주흥(Ju Hung Song) 대한내과학회 2002 대한내과학회지 Vol.62 No.6
The hemorrhage in hemorrhagic fever with renal syndrome (HFRS) varies from transient petechial lesions to fulminant and massive bleeding. Also in vital organ such as lung, kidney, spleen, brain and pituitary, hemorrhage occasionally occurs spontaneously or by minor trauma. We report a case of retroperitoneal hematoma by spontaneous rupture of renal capsule in HFRS presented with anuria and right flank pain. A 34-year-old male was admitted to our hospital presenting anuria and right flank pain for 3 days. He also had suffered from fever and myalgia since 5 days ago. Sonography and computed tomography were performed at the day of hospitalization and showed massive perirenal hematoma with ruptured renal capsule and spurtting subcapsular renal artery on the right kidney. He was diagnosed as HFRS and treated with hemodialysis, fluid infusion and transfusion. After conservative treatment, he recovered from HFRS without further blood loss.(Korean J Med 62:671-674, 2002)
유지혈액투석 환자에서 안지오텐신 전환효소 유전자 다형성에 따른 sRAGE의 변화
이강원 ( Kang Won Lee ),차정민 ( Jeong Min Cha ),이유민 ( Yu Min Lee ),박석돈 ( Seok Don Park ),송주흥 ( Ju Hung Song ),안선호 ( Seon Ho Ahn ) 대한내과학회 2013 대한내과학회지 Vol.85 No.5
Background/Aims: Advanced glycation end-products (AGEs) exert various toxic effects through the receptor for AGEs (RAGE). Soluble RAGE (sRAGE) is a naturally occurring inhibitor of AGE-RAGE. Recent studies have suggested that inhibition of angiotensin-converting enzyme (ACE) reduces the accumulation of AGEs in diabetes partly by increasing the production and secretion of sRAGE into the plasma. This report describes the relationship between sRAGE and ACE polymorphism in maintenance hemodialysis patients. Methods: The levels of sRAGE and advanced oxidation protein products (AOPPs) were assessed by enzyme-linked immunosorbent assay (ELISA), and ACE polymorphism was detected by PCR amplification. Results: The distributions of ACE genotypes in 105 hemodialysis patients were as follows: II, 56 (35.9%); ID, 29 (18.6%); and DD, 20 (12.8%). According to the ACE genotypes, the study group consisted of II (n = 56) and ID + DD group (n = 49). sRAGE was correlated with age (r = -0.24; p = 0.013). There were significant differences in sRAGE, AOPP, age, duration of dialysis, C-reactive protein, or 24-h urine volume between two genotype groups. There were no significant differences in sRAGE levels, even though the effect of age was treated as a covariate. Conclusions: Our findings suggested that sRAGE may be affected only by age, and not by ACE polymorphism in maintenance hemodialysis patients. (Korean J Med 2013;85:495-502)